Here we find the unanticipated segregation of both treatment-naïve gliomas as well as recurrent glioblastoma based on IDH1 mutation status within hallmarks of “invasion motility”, “proliferative signaling”, and “inducing angiogenesis”. The gene discussed is IDH1; the disease is glioblastoma.